from Reuters: Technology News https://ift.tt/2B1Aao7
Friday, October 11, 2019
SoftBank-backed Vir Biotechnology's shares tumble in market debut
Shares of SoftBank-backed Vir Biotechnology Inc plunged nearly 19.3% on their debut on Friday, adding to the gloom in the IPO market following WeWork's failed attempt to list on the stock market.
from Reuters: Technology News https://ift.tt/2B1Aao7
from Reuters: Technology News https://ift.tt/2B1Aao7
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment